WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility
Posted: Sep 29th, 2014In: Press ReleasesNeoStem announces $20 million term loan financing from Oxford Finance LLC
Read More about WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt FacilityWBB Securities Sponsors BioCentury’s 21st Annual NewsMakers Conference
Posted: Sep 29th, 2014In: Press ReleasesExecutive Teams of Emerging Biotech Companies Present to Investor Community
Read More about WBB Securities Sponsors BioCentury’s 21st Annual NewsMakers ConferenceWhy the Ebola Crisis Won’t End Without Military Intervention
Posted: Sep 16th, 2014In: Opinions & FeaturesEbola has evoked our worst nightmares as it continues to outrun containment efforts.
Read More about Why the Ebola Crisis Won’t End Without Military InterventionRetrophin, Gilead, and Our Healthcare Values
Posted: Sep 12th, 2014In: Opinions & FeaturesHave you ever wondered how our society values innovation, how it rewards breakthrough discoveries? Most people say that it’s the price we place on new drugs that show how much we value the breakthrough.[...]
Read More about Retrophin, Gilead, and Our Healthcare ValuesAnalyst Interview with Steve Brozak: Big-Picture Biotech Stocks Rule the Future
Posted: Sep 8th, 2014In: Opinions & FeaturesSteve Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system, which he believes will be unsustainable without therapies that work more[...]
Read More about Analyst Interview with Steve Brozak: Big-Picture Biotech Stocks Rule the Future